Vera Therapeutics (VERA) Debt Ratio (2021 - 2023)

Vera Therapeutics (VERA) reported Debt Ratio of 0.01 for Q1 2023, down 63.61% on a YoY basis from 0.04 in Q1 2022, and down 30.75% quarter-over-quarter from 0.02 in Q4 2022.

Vera Therapeutics (VERA) Debt Ratio (2021 - 2023) Analysis & Trends

Vera Therapeutics has reported Debt Ratio for 3 years, with the latest figure at 0.01 in Q1 2023.

  • For the quarter ending Q1 2023, Debt Ratio fell 63.61% year-over-year to 0.01; the trailing twelve-month figure through Mar 2023 stood at 0.01 (down 63.61% YoY), and the FY2022 full-year result was 0.02, down 70.59% from the prior year.
  • Debt Ratio for Q1 2023 stood at 0.01, down from 0.02 in the prior quarter.
  • The five-year high for Debt Ratio was 0.07 in Q4 2021, with the low at 0.01 in Q3 2021.
  • Historically, Debt Ratio has averaged 0.04 across 3 years, with a median of 0.04 in 2022.
  • The largest YoY upside for Debt Ratio was 319.18% in 2022 against a maximum downside of 70.59% in 2022.
  • Vera Therapeutics' Debt Ratio stood at 0.07 in 2021, then slumped by 70.59% to 0.02 in 2022, then slumped by 30.75% to 0.01 in 2023.
  • The last three Debt Ratio figures came in at 0.01 (Q1 2023), 0.02 (Q4 2022), and 0.05 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Vera Therapeutics 2.51 Bn 1.91 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.01
Dec 31, 2022 0.02
Sep 30, 2022 0.05
Jun 30, 2022 0.05
Mar 31, 2022 0.04
Dec 31, 2021 0.07
Sep 30, 2021 0.01